• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Natural Killer Cells in Liver Disease and Hepatocellular Carcinoma and the NK Cell-Based Immunotherapy.自然杀伤细胞在肝脏疾病和肝细胞癌中的作用及基于 NK 细胞的免疫治疗。
J Immunol Res. 2018 Sep 4;2018:1206737. doi: 10.1155/2018/1206737. eCollection 2018.
2
Natural Killer Cells and T Cells in Hepatocellular Carcinoma and Viral Hepatitis: Current Status and Perspectives for Future Immunotherapeutic Approaches.自然杀伤细胞和 T 细胞在肝细胞癌和病毒性肝炎中的作用:当前现状及未来免疫治疗方法的展望。
Cells. 2021 May 28;10(6):1332. doi: 10.3390/cells10061332.
3
Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy.肝细胞癌中的自然杀伤细胞功能障碍及基于自然杀伤细胞的免疫疗法。
Acta Pharmacol Sin. 2015 Oct;36(10):1191-9. doi: 10.1038/aps.2015.41. Epub 2015 Jun 15.
4
T and NK Cell-Based Immunotherapy in Chronic Viral Hepatitis and Hepatocellular Carcinoma.基于 T 细胞和自然杀伤细胞的免疫疗法在慢性病毒性肝炎和肝细胞癌中的应用。
Cells. 2022 Jan 6;11(2):180. doi: 10.3390/cells11020180.
5
Natural Killer Cell Dysfunction in Hepatocellular Carcinoma: Pathogenesis and Clinical Implications.自然杀伤细胞功能障碍在肝细胞癌中的作用:发病机制与临床意义。
Int J Mol Sci. 2018 Nov 19;19(11):3648. doi: 10.3390/ijms19113648.
6
Immune signature and therapeutic approach of natural killer cell in chronic liver disease and hepatocellular carcinoma.慢性肝病和肝细胞癌中自然杀伤细胞的免疫特征和治疗方法。
J Gastroenterol Hepatol. 2024 Sep;39(9):1717-1727. doi: 10.1111/jgh.16584. Epub 2024 May 27.
7
Taste receptor T1R1/T1R3 promotes the tumoricidal activity of hepatic CD49a CD49b natural killer cells.味觉受体 T1R1/T1R3 促进肝 CD49a CD49b 自然杀伤细胞的杀瘤活性。
Eur J Immunol. 2018 Dec;48(12):2031-2041. doi: 10.1002/eji.201847688. Epub 2018 Oct 10.
8
hIL-15 gene-modified human natural killer cells (NKL-IL15) augments the anti-human hepatocellular carcinoma effect in vivo.人白细胞介素-15基因修饰的人自然杀伤细胞(NKL-IL15)增强体内抗人肝癌效应。
Immunobiology. 2014 Jul;219(7):547-53. doi: 10.1016/j.imbio.2014.03.007. Epub 2014 Mar 20.
9
Adoptive transfer of TRAIL-expressing natural killer cells prevents recurrence of hepatocellular carcinoma after partial hepatectomy.转输表达肿瘤坏死因子相关凋亡诱导配体的自然杀伤细胞可预防部分肝切除术后肝细胞癌的复发。
Transplantation. 2006 Dec 27;82(12):1712-9. doi: 10.1097/01.tp.0000250935.41034.2d.
10
NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma.乙型肝炎病毒感染和肝细胞癌中的自然杀伤细胞受体失衡与自然杀伤细胞功能障碍
Cell Mol Immunol. 2015 May;12(3):292-302. doi: 10.1038/cmi.2014.91. Epub 2014 Oct 13.

引用本文的文献

1
Identification of immune escape-related prognostic genes and immune infiltration analysis in hepatocellular carcinoma based on bioinformatics.基于生物信息学的肝细胞癌免疫逃逸相关预后基因鉴定及免疫浸润分析
Biochem Biophys Rep. 2025 Jul 29;43:102181. doi: 10.1016/j.bbrep.2025.102181. eCollection 2025 Sep.
2
SPDL1 overexpression was associated with poor prognosis and immune status in HCC through in vitro experiment and bioinformatics analysis.通过体外实验和生物信息学分析,SPDL1过表达与肝癌的不良预后和免疫状态相关。
Discov Oncol. 2025 Jul 11;16(1):1310. doi: 10.1007/s12672-025-03089-8.
3
Insulin Modulates NK Cell Activity in Liver Fibrosis MASH Patients via the STING Pathway.胰岛素通过STING通路调节肝纤维化MASH患者的自然杀伤细胞活性。
Cells. 2025 Jun 20;14(13):941. doi: 10.3390/cells14130941.
4
Advancing Adjuvant Immunotherapy in Hepatocellular Carcinoma: A Comprehensive Review.肝细胞癌辅助免疫治疗的进展:综述
Immunotargets Ther. 2025 Jun 25;14:631-654. doi: 10.2147/ITT.S528709. eCollection 2025.
5
Single-cell sequencing combined with bulk RNA seq reveals the roles of natural killer cell in prognosis and immunotherapy of hepatocellular carcinoma.单细胞测序联合批量RNA测序揭示自然杀伤细胞在肝细胞癌预后和免疫治疗中的作用。
Sci Rep. 2025 May 1;15(1):15314. doi: 10.1038/s41598-025-99638-w.
6
Immune microenvironment and immunotherapy in hepatocellular carcinoma: mechanisms and advances.肝细胞癌中的免疫微环境与免疫治疗:机制与进展
Front Immunol. 2025 Apr 2;16:1581098. doi: 10.3389/fimmu.2025.1581098. eCollection 2025.
7
The role of immune regulation in HBV infection and hepatocellular carcinogenesis.免疫调节在乙肝病毒感染及肝细胞癌发生过程中的作用。
Front Immunol. 2025 Mar 14;16:1506526. doi: 10.3389/fimmu.2025.1506526. eCollection 2025.
8
The Prognostic Value and Immunomodulatory Role of Spsb2, a Novel Immune Checkpoint Molecule, in Hepatocellular Carcinoma.新型免疫检查点分子Spsb2在肝细胞癌中的预后价值及免疫调节作用
Genes (Basel). 2025 Mar 17;16(3):346. doi: 10.3390/genes16030346.
9
Boosting tumor homing of endogenous natural killer cells via therapeutic secretomes of chemically primed natural killer cells.通过化学预处理的自然杀伤细胞的治疗性分泌产物增强内源性自然杀伤细胞的肿瘤归巢能力。
J Immunother Cancer. 2025 Mar 5;13(3):e010371. doi: 10.1136/jitc-2024-010371.
10
Physical activity and exercise in liver cancer.肝癌中的体力活动与运动
Liver Res. 2024 Mar 8;8(1):22-33. doi: 10.1016/j.livres.2024.03.001. eCollection 2024 Mar.

本文引用的文献

1
Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity.阻断检查点受体 TIGIT 可防止 NK 细胞耗竭并引发强大的抗肿瘤免疫。
Nat Immunol. 2018 Jul;19(7):723-732. doi: 10.1038/s41590-018-0132-0. Epub 2018 Jun 18.
2
Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma.开发针对 GPC3 的嵌合抗原受体工程化自然杀伤细胞用于治疗肝细胞癌。
Mol Ther. 2018 Feb 7;26(2):366-378. doi: 10.1016/j.ymthe.2017.12.012. Epub 2017 Dec 19.
3
An important discovery on combination of irreversible electroporation and allogeneic natural killer cell immunotherapy for unresectable pancreatic cancer.不可逆电穿孔与异基因自然杀伤细胞免疫疗法联合治疗不可切除胰腺癌的一项重要发现。
Oncotarget. 2017 Oct 19;8(60):101795-101807. doi: 10.18632/oncotarget.21974. eCollection 2017 Nov 24.
4
Suppression of Natural Killer Cell Activity by Regulatory NKT10 Cells Aggravates Alcoholic Hepatosteatosis.调节性NKT10细胞对自然杀伤细胞活性的抑制会加重酒精性肝脂肪变性。
Front Immunol. 2017 Oct 30;8:1414. doi: 10.3389/fimmu.2017.01414. eCollection 2017.
5
Cryoablation combined with allogenic natural killer cell immunotherapy improves the curative effect in patients with advanced hepatocellular cancer.冷冻消融联合同种异体自然杀伤细胞免疫疗法可提高晚期肝细胞癌患者的疗效。
Oncotarget. 2017 May 11;8(47):81967-81977. doi: 10.18632/oncotarget.17804. eCollection 2017 Oct 10.
6
Novel treatments for chronic hepatitis C: closing the remaining gaps.新型慢性丙型肝炎治疗方法:弥合尚存差距。
Curr Opin Pharmacol. 2017 Dec;37:107-111. doi: 10.1016/j.coph.2017.10.001. Epub 2017 Nov 6.
7
Clinical grade manufacturing of genetically modified, CAR-expressing NK-92 cells for the treatment of ErbB2-positive malignancies.用于治疗 ErbB2 阳性恶性肿瘤的基因修饰、CAR 表达 NK-92 细胞的临床级制造。
Cancer Immunol Immunother. 2018 Jan;67(1):25-38. doi: 10.1007/s00262-017-2055-2. Epub 2017 Sep 6.
8
Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity.经基因工程改造表达 IL-15 和靶向 CD19 的 CAR 的脐血 NK 细胞具有长期持久性和强大的抗肿瘤活性。
Leukemia. 2018 Feb;32(2):520-531. doi: 10.1038/leu.2017.226. Epub 2017 Jul 20.
9
Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers.自然杀伤细胞上程序性细胞死亡蛋白1表达增加会抑制自然杀伤细胞介导的抗肿瘤功能,并提示消化系癌症预后不良。
Oncogene. 2017 Nov 2;36(44):6143-6153. doi: 10.1038/onc.2017.209. Epub 2017 Jul 10.
10
Engineering Natural Killer Cells for Cancer Immunotherapy.用于癌症免疫治疗的工程化自然杀伤细胞
Mol Ther. 2017 Aug 2;25(8):1769-1781. doi: 10.1016/j.ymthe.2017.06.012. Epub 2017 Jun 28.

自然杀伤细胞在肝脏疾病和肝细胞癌中的作用及基于 NK 细胞的免疫治疗。

Natural Killer Cells in Liver Disease and Hepatocellular Carcinoma and the NK Cell-Based Immunotherapy.

机构信息

Laboratory of Department of Hematology, Yishui Central Hospital of Linyi, Linyi, China.

出版信息

J Immunol Res. 2018 Sep 4;2018:1206737. doi: 10.1155/2018/1206737. eCollection 2018.

DOI:10.1155/2018/1206737
PMID:30255103
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6142725/
Abstract

Nature killer (NK) cells play a critical role in host innate and adaptive immune defense against viral infections and tumors. NK cells are enriched in liver hematopoietic cells with unique NK repertories and functions to safeguard liver cells against hepatitis virus infection or malignancy transformation. However, accumulating evidences were found that the NK cells were modulated by liver diseases and liver cancers including hepatocellular carcinoma (HCC) and showed impaired functions failing to activate the elimination of the viral-infected cells or tumor cells and were further involved in the pathogenesis of liver injury and inflammation. The full characterization of circulation and intrahepatic NK cell phenotype and function in liver disease and liver cancer has not only provided new insight into the disease pathogenesis but has also discovered new targets for developing new NK cell-based therapeutic strategies. This review will discuss and summarize the NK cell phenotypic and functional changes in liver disease and HCC, and the NK cell-based immunotherapy approaches and progresses for cancers including HCC will also be reviewed.

摘要

自然杀伤 (NK) 细胞在宿主先天和适应性免疫防御病毒感染和肿瘤方面发挥着关键作用。NK 细胞富含具有独特 NK repertoire 和功能的肝脏造血细胞,可保护肝细胞免受肝炎病毒感染或恶性转化。然而,越来越多的证据表明,NK 细胞被肝脏疾病和肝癌(包括肝细胞癌 (HCC))所调节,其功能受损,无法激活清除受病毒感染的细胞或肿瘤细胞,并且进一步参与肝脏损伤和炎症的发病机制。对肝脏疾病和肝癌中循环和肝内 NK 细胞表型和功能的全面描述不仅为疾病发病机制提供了新的见解,而且还为开发基于 NK 细胞的新治疗策略发现了新的靶点。本综述将讨论和总结肝脏疾病和 HCC 中 NK 细胞的表型和功能变化,以及基于 NK 细胞的免疫治疗方法在 HCC 等癌症中的进展。